Literature DB >> 11832362

Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats.

Gregory R Steinberg1, Arend Bonen, David J Dyck.   

Abstract

Leptin acutely increases fatty acid (FA) oxidation and triacylglycerol (TG) hydrolysis and decreases TG esterification in oxidative rodent muscle. However, the effects of chronic leptin administration on FA metabolism in skeletal muscle have not been examined. We hypothesized that chronic leptin treatment would enhance TG hydrolysis as well as the capacity to oxidize FA in soleus (SOL) muscle. Female Sprague-Dawley rats were infused for 2 wk with leptin (LEPT; 0.5 mg x kg(-1) x day(-1)) by use of subcutaneously implanted miniosmotic pumps. Control (AD-S) and pair-fed (PF-S) animals received saline-filled implants. Subsequently, FA metabolism was monitored for 45 min in isolated, resting, and contracting (20 tetani/min) SOL muscles by means of pulse-chase procedures. Food intake (-33 +/- 2%, P < 0.01) and body mass (-12.5 +/- 4%, P = 0.01) were reduced in both LEPT and PF-S animals. Leptin levels were elevated (+418 +/- 7%, P < 0.001) in treated animals but reduced in PF-S animals (-73 +/- 8%, P < 0.05) relative to controls. At rest, TG hydrolysis was increased in leptin-treated rats (1.8 +/- 2.2, AD-S vs. 23.5 +/- 8.1 nmol/g wet wt, LEPT; P < 0.001). In contracting SOL muscles, TG hydrolysis (1.5 +/- 0.6, AD-S vs. 3.6 +/- 1.0 micromol/g wet wt, LEPT; P = 0.02) and palmitate oxidation (18.3 +/- 6.7, AD-S vs. 45.7 +/- 9.9 nmol/g wet wt, LEPT; P < 0.05) were both significantly increased by leptin treatment. Chronic leptin treatment had no effect on TG esterification either at rest or during contraction. Markers of overall (citrate synthase) and FA (hydroxyacyl-CoA dehydrogenase) oxidative capacity were unchanged with leptin treatment. Protein expression of hormone-sensitive lipase (HSL) was also unaltered following leptin treatment. Thus leptin-induced increases in lipolysis are likely due to HSL activation (i.e., phosphorylation). Increased FA oxidation secondary to chronic leptin treatment is not due to an enhanced oxidative capacity and may be a result of enhanced flux into the mitochondrion (i.e., carnitine palmitoyltransferase I regulation) or electron transport uncoupling (i.e., uncoupling protein-3 expression).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832362     DOI: 10.1152/ajpendo.00303.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  22 in total

1.  Development and validation of a high-throughput screening assay for human long-chain fatty acid transport proteins 4 and 5.

Authors:  Wei Zhou; Peter Madrid; Amy Fluitt; Andreas Stahl; Xinmin Simon Xie
Journal:  J Biomol Screen       Date:  2010-05-06

2.  Effectual comparison of quinoa and amaranth supplemented diets in controlling appetite; a biochemical study in rats.

Authors:  M V Mithila; Farhath Khanum
Journal:  J Food Sci Technol       Date:  2015-01-16       Impact factor: 2.701

3.  Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice.

Authors:  Undi Hoffler; Kristen Hobbie; Ralph Wilson; Re Bai; Akef Rahman; David Malarkey; Greg Travlos; Burhan I Ghanayem
Journal:  Endocrine       Date:  2009-08-11       Impact factor: 3.633

4.  Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent.

Authors:  J Jeppesen; P H Albers; A J Rose; J B Birk; P Schjerling; N Dzamko; G R Steinberg; B Kiens
Journal:  J Lipid Res       Date:  2011-02-06       Impact factor: 5.922

5.  Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation.

Authors:  Esben Thyssen Vestergaard; Simon Lebech Cichosz; Niels Møller; Jens Otto Lunde Jørgensen; Jesper Fleischer
Journal:  Br J Clin Pharmacol       Date:  2017-08-24       Impact factor: 4.335

6.  Caloric restriction in leptin deficiency does not correct myocardial steatosis: failure to normalize PPAR{alpha}/PGC1{alpha} and thermogenic glycerolipid/fatty acid cycling.

Authors:  J Eduardo Rame; Lili A Barouch; Michael N Sack; Edward G Lynn; Mones Abu-Asab; Maria Tsokos; Steven J Kern; Jennifer J Barb; Peter J Munson; Marc K Halushka; Karen L Miller; Karen Fox-Talbot; Jianhua Zhang; Joshua M Hare; Michael A Solomon; Robert L Danner
Journal:  Physiol Genomics       Date:  2011-03-22       Impact factor: 3.107

Review 7.  Hormone-sensitive lipase--new roles for an old enzyme.

Authors:  Stephen J Yeaman
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

8.  Impairment of mitochondrial beta-oxidation in rats under cold-hypoxic environment.

Authors:  Arkadeb Dutta; Praveen Vats; Vijay K Singh; Yogendra K Sharma; Som N Singh; Shashi B Singh
Journal:  Int J Biometeorol       Date:  2009-04-25       Impact factor: 3.787

Review 9.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

10.  AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.

Authors:  Nicolas Dzamko; Jonathan D Schertzer; James G Ryall; Rohan Steel; S Lance Macaulay; Sheena Wee; Zhi-Ping Chen; Belinda J Michell; Jonathan S Oakhill; Matthew J Watt; Sebastian Beck Jørgensen; Gordon S Lynch; Bruce E Kemp; Gregory R Steinberg
Journal:  J Physiol       Date:  2008-10-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.